Curran Terrie

CIK 00016902984 companiesWESTLAKE VILLAGE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001690298

Recent Transactions

50 trades

Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2025-06-12+7,609→ 17,748 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2025-06-12+20,568→ 20,568 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2025-02-27+342,500→ 342,500 total
Sale
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-01-21$6.59/sh−19,109→ 360,465 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2024-11-11$10.85/sh−8,687→ 10,139 total
Sale
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2024-07-15$11.72/sh−33,848→ 377,734 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2024-06-14+10,139→ 18,826 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2024-06-14+27,052→ 27,052 total
Sale
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2024-03-22$9.11/sh−16,851→ 410,784 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2024-01-18+475,000→ 475,000 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2023-11-01+37,500→ 427,171 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2023-07-14+200,000→ 389,671 total
Disposition to Issuer
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option
2023-07-14−175,000→ 0 total
Disposition to Issuer
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option
2023-07-14−225,000→ 0 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2023-05-31+4,375→ 8,687 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2023-05-31+12,220→ 12,220 total
Purchase
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2023-04-06$7.82/sh+12,919→ 188,290 total
Disposition to Issuer
Myovant Sciences Ltd.
Common Shares
2023-03-10−3,673→ 0 total
Disposition to Issuer
Myovant Sciences Ltd.
Stock Options (Right to Buy)
2023-03-10−22,500→ 0 total
Disposition to Issuer
Myovant Sciences Ltd.
Stock Options (Right to Buy)
2023-03-10−33,846→ 0 total
Disposition to Issuer
Myovant Sciences Ltd.
Stock Options (Right to Buy)
2023-03-10−21,096→ 0 total
Disposition to Issuer
Myovant Sciences Ltd.
Stock Options (Right to Buy)
2023-03-10−21,603→ 0 total
Disposition to Issuer
Myovant Sciences Ltd.
Stock Options (Right to Buy)
2023-03-10−22,500→ 0 total
Disposition to Issuer
Myovant Sciences Ltd.
Stock Options (Right to Buy)
2023-03-10−5,250→ 0 total
Disposition to Issuer
Myovant Sciences Ltd.
Stock Options (Right to Buy)
2023-03-10−11,154→ 0 total
Sale
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2023-03-01$8.54/sh−1,436→ 175,371 total
Sale
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2023-01-20$8.20/sh−5,821→ 176,807 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2023-01-19+97,500→ 182,628 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2023-01-19+162,500→ 162,500 total
Sale
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2022-11-21$9.60/sh−1,526→ 83,720 total
Award
Myovant Sciences Ltd.
Common Shares
2022-10-26+9,859→ 9,859 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2022-09-01+7,500→ 85,246 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2022-06-01+11,796→ 11,796 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2022-06-01+4,312→ 4,312 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2022-05-19+12,000→ 76,595 total
Purchase
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2022-05-13$7.41/sh+20,500→ 64,595 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2022-01-19+41,250→ 44,095 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2022-01-19+206,250→ 206,250 total
Award
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2021-11-05+21,096→ 21,096 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2021-09-09−4,850→ 5,250 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2021-09-09$7.65/sh+4,850→ 4,850 total
Sale
Myovant Sciences Ltd.
Common Shares
2021-09-09$25.58/sh−4,850→ 0 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2021-09-02$7.65/sh+37,135→ 37,135 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2021-09-02−37,135→ 10,100 total
Sale
Myovant Sciences Ltd.
Common Shares
2021-09-02$25.03/sh−37,135→ 0 total
Sale
Myovant Sciences Ltd.
Common Shares
2021-09-01$25.00/sh−11,373→ 0 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2021-09-01−11,373→ 47,235 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2021-09-01$7.65/sh+11,373→ 11,373 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2021-06-09+13,391→ 13,391 total
Exercise/Conversion
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2021-03-22−11,513→ 855,687 total

Companies

Recent Filings

Address

C/O ARCUTIS BIOTHERAPEUTICS, INC. 3027 TOWNSGATE ROAD, SUITE 300

WESTLAKE VILLAGE, CA, 91361

View on SEC.gov